Whalesbook
Piramal Pharma's bioconjugates manufacturing facility in Grangemouth, Scotland, has received updated Good Manufacturing Practice (GMP) certificates from the UK's Medicines and Healthcare products Regulatory Agency (MHRA). These certificates are valid for three years and cover all operations at the Helix building, including its warehouse and laboratory. The approval reinforces the facility's regulatory standing and supports ongoing client programs.